Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Cytomegalovirus-induced salivary gland pathology: AREG, FGF8, TNF-α, and IL-6 signal dysregulation and neoplasia.

Melnick M, Deluca KA, Sedghizadeh PP, Jaskoll T.

Exp Mol Pathol. 2013 Apr;94(2):386-97. doi: 10.1016/j.yexmp.2013.01.005. Epub 2013 Feb 8.

PMID:
23399805
2.

Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship.

Melnick M, Sedghizadeh PP, Allen CM, Jaskoll T.

Exp Mol Pathol. 2012 Feb;92(1):118-25. doi: 10.1016/j.yexmp.2011.10.011. Epub 2011 Nov 10.

PMID:
22101257
3.

Small molecule inhibitors of the host cell COX/AREG/EGFR/ERK pathway attenuate cytomegalovirus-induced pathogenesis.

Melnick M, Abichaker G, Htet K, Sedghizadeh P, Jaskoll T.

Exp Mol Pathol. 2011 Aug;91(1):400-10. doi: 10.1016/j.yexmp.2011.04.014. Epub 2011 May 1.

4.

CMV-induced pathology: pathway and gene-gene interaction analysis.

Melnick M, Deluca KA, Jaskoll T.

Exp Mol Pathol. 2014 Aug;97(1):154-65. doi: 10.1016/j.yexmp.2014.06.011. Epub 2014 Jun 28.

PMID:
24984270
5.

Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.

Chen Z, Chen J, Gu Y, Hu C, Li JL, Lin S, Shen H, Cao C, Gao R, Li J, Ha PK, Kaye FJ, Griffin JD, Wu L.

Oncogene. 2014 Jul 17;33(29):3869-77. doi: 10.1038/onc.2013.348. Epub 2013 Aug 26.

PMID:
23975434
7.
8.

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.

Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.

Oncogene. 2010 Sep 2;29(35):4947-58. doi: 10.1038/onc.2010.240. Epub 2010 Jun 21.

PMID:
20562913
9.

Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.

Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE.

Laryngoscope. 2001 Aug;111(8):1373-8.

PMID:
11568571
10.

Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.

Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.

J Pharmacol Exp Ther. 2009 Jun;329(3):1063-70. doi: 10.1124/jpet.108.147306. Epub 2009 Mar 3.

11.

Two modes of ERK activation by TNF in keratinocytes: different cellular outcomes and bi-directional modulation by vitamin D.

Ziv E, Rotem C, Miodovnik M, Ravid A, Koren R.

J Cell Biochem. 2008 May 15;104(2):606-19.

PMID:
18080320
12.

EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells.

Martínez-Palacián A, del Castillo G, Herrera B, Fernández M, Roncero C, Fabregat I, Sánchez A.

Cell Signal. 2012 Feb;24(2):505-13. doi: 10.1016/j.cellsig.2011.09.031. Epub 2011 Oct 7.

PMID:
22001397
13.

Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes.

Na X, Zhao D, Koon HW, Kim H, Husmark J, Moyer MP, Pothoulakis C, LaMont JT.

Gastroenterology. 2005 Apr;128(4):1002-11.

PMID:
15825081
14.

MUC5AC expression through bidirectional communication of Notch and epidermal growth factor receptor pathways.

Kang JH, Lee EH, Park SW, Chung IY.

J Immunol. 2011 Jul 1;187(1):222-9. doi: 10.4049/jimmunol.1003606. Epub 2011 May 27.

15.

EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation.

Kim SE, Choi KY.

Cell Signal. 2007 Jul;19(7):1554-64. Epub 2007 Feb 20.

PMID:
17374561
16.

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival.

Zheng B, Fiumara P, Li YV, Georgakis G, Snell V, Younes M, Vauthey JN, Carbone A, Younes A.

Blood. 2003 Aug 1;102(3):1019-27. Epub 2003 Apr 10.

17.

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C.

Cancer Res. 2006 Dec 15;66(24):11851-8.

18.

Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells.

Kim SJ, Kim SY, Kwon CH, Kim YK.

Growth Factors. 2007 Apr;25(2):77-86.

PMID:
17852407
19.

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Roberts PJ, Der CJ.

Oncogene. 2007 May 14;26(22):3291-310. Review.

PMID:
17496923
20.

Neutrophil elastase-initiated EGFR/MEK/ERK signaling counteracts stabilizing effect of autocrine TGF-beta on tropoelastin mRNA in lung fibroblasts.

DiCamillo SJ, Yang S, Panchenko MV, Toselli PA, Naggar EF, Rich CB, Stone PJ, Nugent MA, Panchenko MP.

Am J Physiol Lung Cell Mol Physiol. 2006 Aug;291(2):L232-43. Epub 2006 Feb 10.

Supplemental Content

Support Center